BriaCell Therapeutics Corp. Warrant expiring 2031 (NASDAQ: BCTXL) last traded at $1.08, up 5.78% on the session. The quote above updates while this page is open; the figures below are drawn from BriaCell Therapeutics Corp. Warrant expiring 2031’s own filings and are restated only when a new one is published.
BriaCell Therapeutics Corp. Warrant expiring 2031 trades on NASDAQ under the ticker BCTXL. Its market capitalisation is $9.40 million.
Valuation measures for BriaCell Therapeutics Corp. Warrant expiring 2031, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.40M |
|---|---|
| Enterprise value | $6.18M |
| Price / book | 0.40 |
Trailing-twelve-month figures tagged in BriaCell Therapeutics Corp. Warrant expiring 2031's XBRL filings with the SEC.
| Net income (TTM) | -$30.68M |
|---|
| Return on equity | -131.04% |
|---|
| Cash | $6.88M |
|---|
Range and volume for BCTXL over the past 52 weeks.
| 52-week high | $1.08 |
|---|---|
| 52-week low | $1.05 |
| Volume | 3.7K |
| Average volume | 3.7K |
| Previous close | $1.02 |
Invest a chosen dollar amount in BriaCell Therapeutics Corp. Warrant expiring 2031 with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BCTXL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.